Pregnancy and asymptomatic carriage of Pneumocystis jiroveci.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

30 citing papers in PubMed.

1. Journal of fungi (Basel, Switzerland) · 2025
   Review
2. Avicenna journal of medicine · 2023
   Review
3. Concurrent Infection with SARS-CoV-2 andJournal of fungi (Basel, Switzerland) · 2022
   Review
4. Pneumocystis jirovecii Colonization in Preterm Newborns With Respiratory Distress Syndrome.The Journal of infectious diseases · 2022
   Article
5. Sero-Epidemiology ofJournal of fungi (Basel, Switzerland) · 2022
   Article
6. Transmission and Colonization ofJournal of fungi (Basel, Switzerland) · 2021
   Review
7. Outbreak-Causing Fungi: Pneumocystis jirovecii.Mycopathologia · 2020
   Review
8. A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.Clinical microbiology reviews · 2018
   Review
9. In vitro and in vivo activity of iclaprim, a diaminopyrimidine compound and potential therapeutic alternative against Pneumocystis pneumonia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
   Article
10. High transient colonization by Pneumocystis jirovecii between mothers and newborn.European journal of pediatrics · 2017
    Article
11. F1000Research · 2017
    Review
12. Pneumocystis jirovecii--from a commensal to pathogen: clinical and diagnostic review.Parasitology research · 2015
    Review
13. SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs.PloS one · 2015
    Article
14. Asymptomatic carriage of Pneumocystis jirovecii and cytomegalovirus in lungs of immunocompetent patients.Lung · 2014
    Observational
15. Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.Journal of acquired immune deficiency syndromes (1999) · 2014
    Article
16. Pneumocystis jirovecii Colonization in Non-HIV-Infected Patients Based on Nested-PCR Detection in Bronchoalveolar Lavage Samples.Iranian journal of public health · 2013
    Article
17. De novo assembly of the Pneumocystis jirovecii genome from a single bronchoalveolar lavage fluid specimen from a patient.mBio · 2012
    Article
18. Colonization by Pneumocystis jirovecii and its role in disease.Clinical microbiology reviews · 2012
    Review
19. Complexity of the MSG gene family of Pneumocystis carinii.BMC genomics · 2009
    Article
20. Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study.BMC infectious diseases · 2009
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as